Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability and Food Effect Study of Irafamdastat in Healthy Adults
NCT07837115Phase 1Recruiting
- Sponsor
- Celgene Corporation
- Start
- Oct 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of irafamdastat, sponsored by Celgene Corporation. Primary endpoints: Maximum observed plasma concentration, Area under the plasma concentration-time curve from time zero extrapolated to infinite time and 1 more. Started Oct 2026; status: recruiting.
02
Drugs
irafamdastat
Beyond the preview
Go deeper on NCT07837115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07837115.